News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Paciente_ensayo
Positive aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
Access to innovation
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial…
Partners - Oryzon Genomics
Leandro_Harillo_Binit_Tech
#NewAlly | "AseBio is a bridge that allows us to connect with important sector leaders to exchange knowledge and resources"
Access to innovation
Meet Binit Tech, our new ally. We talked to Leandro Harillo, Technology Director.
Zeta-AseBio-Biotecnologia
#NewMemberAseBio | 'AseBio is an excellent association that brings together the most important pharmaceutical and biotech companies in the Spanish market under one roof'
Industrial biotechnology
Meet Zeta GmbH, our new member. We talked to Andreas Marchler, CEO of the company and…
Multipartner-AseBio-Biotecnologia
#NewMemberAseBio | "AseBio is the major community of Spanish biotechnology that provides a favourable environment to protect innovation in the biotechnology sector and ensure the exploitation of patents"
Access to innovation
Meet r Multipartner Virtual Data Room, our new member. We talked to María del…
Bexen-AseBio
#NewMemberAseBio | "AseBio is the collective voice of the biotechnology sector"
Healthcare
Meet  Bexen Medical, our new member. We talked to Manuel Sánchez-…
AseBio - BEXEN MEDICAL
Iván_Marcos_Campos_Promega_AseBio
#BIOSPAIN2023Interview | "Biological therapies have become one of the main exponents of Precision Medicine"
BioSpain
Precision medicine has brought about a real revolution in the treatment of some diseases such as…
AseBio - Promega
Oryzon-Asebio-Biotecnologia
ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
Corporate
All resolutions were approved and 35% of the issued shares represented.
Partners - Oryzon Genomics
Biotecnología_AseBio
AseBio and EuropaBio address the challenges of the Pharmaceutical Strategy and NGTs in Europe
Healthcare · Agrifood
During the Presidency of the Council of the European Union, Spain will lead the dialogue on these…
Fundación_Medina_Welab_AseBio
WeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services and capabilities for the discovery and development of new medicines
Innovative drugs
This collaboration allows combining experience and resources for the discovery and development of…
Partners - Fundación Medina